卫办医政发〔2012〕111号各省、自治区、直辖市卫生厅局、食品药品监督管理局,新疆生产建设兵团卫生局、食品药品监督管理局:2012年5月24日,《人民日报》刊发了吉林硅谷医院涉嫌违规开展干细胞诊疗活动的文章(《“唯一获批”医院忽悠患者》)。文章发表后,部分网站进行了转载。卫生部与国家食品药品监督管理局组成联合调查组,对事件相关的吉 Health Administration of the People’s Republic of China [2012] No. 111 Health Bureau of all provinces, autonomous regions and municipalities directly under the Central Government, Food and Drug Administration, Xinjiang Production and Construction Corps Health Bureau, Food and Drug Administration: May 24, 2012, People’s Daily Made an article allegedly carrying out stem cell therapy activities in Jilin Silicon Valley Hospital (“” the only approved “hospital flicker patients”). After the article was published, some websites were reprinted. Ministry of Health and State Food and Drug Administration formed a joint investigation team, the incident-related Kyrgyzstan